December 2, 2022
Dear SRI Colleagues,
For those of you who celebrated, I hope you had a wonderful Thanksgiving with family and friends. Unfortunately, this holiday occurs in the midst of mounting strife throughout the world – from the horrors of war in Ukraine, to protests in major Chinese cities over stringent government policies on COVID-19-related lockdowns, to violent suppression of women’s rights activists by ‘morality police’ in Iran, to recent horrific mass shootings of children in our schools, attendees of gay clubs, as well as terror attacks on worshipers at synagogues and mosques. The rise in racism, anti-semitism, banning of school books on race and sexuality, laws banning a woman’s right to choose and other sexual freedoms, represent other alarming infringements on our freedoms. Clearly, as basic and clinical scientists there is little that we can do to thwart these injustices. However, the recent medical advances achieved through worldwide scientific collaboration, such as rapid development of the SARS-COV-2 vaccine and the very recently reported Phase I clinical trial of a vaccine against HIV that induces broadly neutralizing antibodies to prevent HIV infection (Science, December 2, 2022, volume 378, issue 6623), gives me hope that as scientists, we can make the world a better place.
You may have noticed in a recent email that the SRI will once again offer a Late Breaking Abstract deadline! This submission period will open in the coming days, and close Friday, January 13. Late Breaking Abstracts will be considered for awards and oral session slots - so if you have very recent research to share, please take advantage of this extended deadline! I look forward to seeing even more excellent reproductive science being submitted over the next six weeks and in Brisbane. For those who submitted their research for the regular abstract submission period, the SRI Program Committee will be meeting next week to decide which abstracts submitted for each category will be chosen for plenary, oral and poster sessions, and for awards. Please watch your email mid-December when these notifications are scheduled to be sent. We appreciate your timely response to these emails, so that we can confirm your chosen timeslots .
December is a big month for SRI Grants. As I mentioned in previous messages, the SRI and Bayer Discovery/Innovation Grant program is currently open, but closes December 13. You may view the guidelines for the 2023-2024 grant cycle here to plan your submission. Remember that while the individual submitting an application does not need to initially be a member of the Society, their mentor is required to be an SRI member.
In just a few days, the SRI Council will gather together in my hometown of Dallas, TX, for the first in-person Interim Council Meeting since 2019! While Council has met at the past two Annual Meetings, the December meeting provides an opportunity to focus on the Society for a longer period of time. I look forward to reviewing the strategic plan created pre-COVID, to see how it has evolved given the changes that have occurred over the past three years, and reevaluate priorities. As always, if you have news you would like to see highlighted regarding you or a colleague, please reach out to the SRI Staff.
Carole R. Mendelson, PhD
SRI President, 2022-2023